98 related articles for article (PubMed ID: 20206869)
1. Clinical factors that influence the cardiovascular morbidity in patients with type II diabetes mellitus.
Kyriazis I; Mendrinos D; Saridi M
Eur J Intern Med; 2010 Apr; 21(2):e9. PubMed ID: 20206869
[No Abstract] [Full Text] [Related]
2. The role of the thiazolidinediones in the practical management of patients with type 2 diabetes and cardiovascular risk factors.
Edelman SV
Rev Cardiovasc Med; 2003; 4 Suppl 6():S29-37. PubMed ID: 14668701
[TBL] [Abstract][Full Text] [Related]
3. A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women.
Manson JE; Colditz GA; Stampfer MJ; Willett WC; Krolewski AS; Rosner B; Arky RA; Speizer FE; Hennekens CH
Arch Intern Med; 1991 Jun; 151(6):1141-7. PubMed ID: 2043016
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular risk in the spectrum of type 2 diabetes mellitus.
Ahmed I; Goldstein BJ
Mt Sinai J Med; 2006 Sep; 73(5):759-68. PubMed ID: 17008936
[TBL] [Abstract][Full Text] [Related]
5. [Obesity and cardiovascular morbidity].
Berg A; Bönner G
Dtsch Med Wochenschr; 2005 Apr; 130(14):893-7. PubMed ID: 15800824
[No Abstract] [Full Text] [Related]
6. Reducing cardiovascular disease risk in patients with type 2 diabetes: a message from the National Diabetes Education Program.
Gavin JR; Peterson K; Warren-Boulton E;
Am Fam Physician; 2003 Oct; 68(8):1569-74. PubMed ID: 14596445
[TBL] [Abstract][Full Text] [Related]
7. [Integral control of cardiovascular risk factors in type 2 diabetes in the Pallars Jussà and Sobirà regions (area of influence of the regional hospital of Pallars-Lleida)].
Porres LD; Solans MR; Oña MF; Morilla L; Isarn RM; Milian ES; Pujol LE
Rev Clin Esp; 2010; 210(7):332-7. PubMed ID: 20510408
[TBL] [Abstract][Full Text] [Related]
8. Post-challenge hyperglycaemia is associated with premature death and macrovascular complications.
Qiao Q; Tuomilehto J; Borch-Johnsen K
Diabetologia; 2003 Mar; 46 Suppl 1():M17-21. PubMed ID: 12652354
[TBL] [Abstract][Full Text] [Related]
9. Management of type 2 diabetes mellitus: is it in accordance with the guidelines?
Chan GC; Ghazali O; Khoo EM
Med J Malaysia; 2005 Dec; 60(5):578-84. PubMed ID: 16515108
[TBL] [Abstract][Full Text] [Related]
10. [Diabetic complications in newly-diagnosed non-insulin-dependent diabetes].
Uusitupa M; Siitonen O; Lehtinen J; Teräsvirta M; Pyörälä K
Duodecim; 1986; 102(15):1024-34. PubMed ID: 3757840
[No Abstract] [Full Text] [Related]
11. [Microalbuminuria is an early marker for increased morbidity and mortality].
Bramlage P; Wittchen HU; Pittrow D; Dikow R; Kirch W; Lehnert H; Ritz E
Fortschr Med Orig; 2003 Feb; 121 Suppl 1():28-32. PubMed ID: 14732947
[TBL] [Abstract][Full Text] [Related]
12. Reducing cardiovascular risk in patients with type 2 diabetes mellitus.
Nicholls SJ; Rydén L
Eur J Cardiovasc Prev Rehabil; 2010 May; 17 Suppl 1():S1. PubMed ID: 20489414
[No Abstract] [Full Text] [Related]
13. Diabetes mellitus: a cardiovascular disease.
Candido R; Srivastava P; Cooper ME; Burrell LM
Curr Opin Investig Drugs; 2003 Sep; 4(9):1088-94. PubMed ID: 14582453
[TBL] [Abstract][Full Text] [Related]
14. Fenofibrate for cardiovascular disease prevention in metabolic syndrome and type 2 diabetes mellitus.
Steiner G
Am J Cardiol; 2008 Dec; 102(12A):28L-33L. PubMed ID: 19084087
[TBL] [Abstract][Full Text] [Related]
15. Mixed dyslipidemia, metabolic syndrome, diabetes mellitus, and cardiovascular disease: clinical implications.
Cannon CP
Am J Cardiol; 2008 Dec; 102(12A):5L-9L. PubMed ID: 19084083
[TBL] [Abstract][Full Text] [Related]
16. Therapy and clinical trials: diabetes and cardiovascular risk.
Peter R
Curr Opin Lipidol; 2008 Feb; 19(1):101-3. PubMed ID: 18196995
[No Abstract] [Full Text] [Related]
17. [Dyslipidemia and cardiovascular risk in type 2 diabetes mellitus patients with associated diabetic nephropathy].
Martínez-Castelao A; Ramos R; González MT; Castiñeiras MJ
Nefrologia; 2002; 22 Suppl 1():51-8. PubMed ID: 11987671
[TBL] [Abstract][Full Text] [Related]
18. Effect of metabolic syndrome or type II diabetes mellitus on the occurrence of recurrent vascular events in hypertensive patients.
Vlek AL; van der Graaf Y; Spiering W; Visseren FL;
J Hum Hypertens; 2008 May; 22(5):358-65. PubMed ID: 18273039
[TBL] [Abstract][Full Text] [Related]
19. The need for tighter control of cardiovascular risk factors in diabetic patients.
Viberti G
J Hypertens Suppl; 2003 Mar; 21(1):S3-6. PubMed ID: 12769160
[TBL] [Abstract][Full Text] [Related]
20. Pulse pressure predicts cardiovascular risk in patients with type 2 diabetes mellitus.
Cockcroft JR; Wilkinson IB; Evans M; McEwan P; Peters JR; Davies S; Scanlon MF; Currie CJ
Am J Hypertens; 2005 Nov; 18(11):1463-7; discussion 1468-9. PubMed ID: 16280282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
